Split History
ETFs Holding NVAX »    NVAX Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Novavax is a late-stage biotechnology company focused on discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including its primary candidates, NanoFlu™ and ResVax™, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. Co.'s technology targets a variety of infectious diseases. Co. is also developing proprietary immune stimulating saponin-based adjuvants at Novavax AB, its wholly owned Swedish subsidiary. According to our NVAX split history records, Novavax has had 1 split.
NVAX split history picture
Novavax (NVAX) has 1 split in our NVAX split history database. The split for NVAX took place on May 10, 2019. This was a 1 for 20 reverse split, meaning for each 20 shares of NVAX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.

When a company such as Novavax conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the NVAX split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Novavax shares, starting with a $10,000 purchase of NVAX, presented on a split-history-adjusted basis factoring in the complete NVAX split history. NVAX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/07/2011
End date: 03/04/2021
Start price/share: $51.20
End price/share: $158.10
Dividends collected/share: $0.00
Total return: 208.79%
Average Annual Total Return: 11.94%
Starting investment: $10,000.00
Ending investment: $30,892.50
Years: 10.00
Date Ratio
05/10/20191 for 20
NVAX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

NVGN Split History
NVIV Split History
NVLS Split History
NVO Split History
NVUS Split History
NWBO Split History
OBLN Split History
OCLS Split History
OCR Split History
OCRX Split History

Also explore: NVAX shares outstanding history

Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
MicroSectors FANG+ Index 2X Leveraged ETNs due January 8, 2038 (FNGO)
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038 (FNGU)
Moleculin Biotech, Inc. (MBRX)
Exela Technologies, Inc. (XELA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

NVAX Insider Buying

NVAX Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.